Ticker Short Interest

ADCT Short Interest Intelligence

ADC Therapeutics SA positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Neutral

Neutral

Bearish Exhaustion Watch

ADCT is classified as Neutral. Latest reported short interest is 6.0M shares; short interest changed -0.2%, price moved -2.9% since the previous report, short interest is in the 71th percentile, and days to cover is in the 29th percentile. Trend context is weak.

Setup Score52/100Neutral
Reported Short Interest6.0M-0.2% vs prior report
Days To Cover3.4028.57 percentile
Price Reaction-2.9%since previous short report
Squeeze Pressure26crowding, trend, and pressure
Bearish Conviction39shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

26

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

39

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

52

Latest short interest is 6.0M shares and days to cover is 3.40.

Divergence

22

Short interest fell while price fell. Shorts are covering despite weak price action, which can suggest the easy bearish pressure may be fading.

Report History

ADCT Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 5993673 6004943 -0.2% 3.40 1763741
15 Jun 2026 6004943 6067857 -1.0% 1.26 4781581
29 May 2026 6067857 5747020 5.6% 7.76 781868
15 May 2026 5747020 5474173 5.0% 3.95 1455366
30 Apr 2026 5474173 5144704 6.4% 5.77 949468
15 Apr 2026 5144704 4901943 5.0% 5.62 915959
31 Mar 2026 4901943 4290199 14.3% 6.27 782295

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.